Targeted Medication Delivery
Medication is delivered directly to the treated sinus tissues.
The Drug-Releasing implant, utilized in EverOpen+ Advanced Sinus Surgery, significantly reduces the chances of needing revision surgeries. This innovative approach ensures long-term sinus patency and relief, minimizing the inconvenience and costs associated with multiple procedures. Experience lasting results with our advanced technique.
The Sinus Link Network is a group of practitioners trained and certified by Dr. Muaaz Tarabichi in the EverOpen+ Advanced Sinus Surgery technique. This network ensures that patients receive the highest quality of care and benefit from the latest advancements in sinus surgery. Find a certified expert near you and take the next step towards lasting relief.
EverOpen+ combines endoscopic sinus surgery with a dissolvable drug-releasing implant designed to help reduce recurring sinus blockage.
The implant gradually delivers anti-inflammatory medication directly to the treated area, helping manage swelling and maintain improved sinus drainage during recovery.
The implant is placed in the treated sinus area during surgery, where it gradually releases anti-inflammatory medication.
Medication is delivered directly to the treated sinus tissues.
The implant helps reduce postoperative swelling that can narrow drainage pathways.
The implant gradually dissolves in approximately 45–60 days.
After sinus surgery, swelling may narrow the treated drainage pathways.
By delivering anti-inflammatory medication during recovery, the EverOpen+ implant helps manage inflammation and maintain improved drainage.
Combined with endoscopic sinus surgery, this approach may reduce the likelihood of sinus blockage returning.
The goal is to support longer-lasting improvements in sinus drainage by addressing inflammation during healing.
Developed by ENT specialist Dr. Muaaz Tarabichi, EverOpen+ integrates endoscopic sinus surgery with drug-releasing implant technology.
The Sinus Link Network supports professional education and collaboration related to this approach.
Explore professional education and collaboration associated with EverOpen+ and advanced sinus care.
A temporary implant that gradually delivers anti-inflammatory medication directly to the treated sinus area following surgery.
It helps manage swelling during recovery, supporting the sinus drainage pathways improved through surgery.
The implant gradually dissolves in approximately 45–60 days.
The implant is designed to dissolve naturally rather than remain permanently.
Suitability is determined by an ENT specialist based on symptoms, medical history and clinical assessment.
Experiencing persistent or recurring sinus symptoms? Learn more about EverOpen+ Advanced Sinus Surgery and available ENT consultation options in Abu Dhabi.
Enquire about EverOpen+, participating ENT specialists and consultation availability.
Contact our team for assistance with consultation enquiries and treatment information.
NMC Royal Hospital, Abu Dhabi, UAE.
Complete the form below and our team can contact you regarding available consultation options.